Results of the Votes of the Combined Shareholders' General Meeting of June 30, 2026
Daix (France), New York City (New York, United States), July 2, 2026 — Inventiva (Euronext Paris and NASDAQ:IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of an oral therapy for the treatment of metabolic dysfunction-associated steatohepat…